What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Ivy Brain Tumor Center

Home
United States
Phoenix, AZ
Ivy Brain Tumor Center

The largest Phase 0 Clinical Trials Program for aggressive brain cancer.

In compliance with federal and state privacy laws, please do not include any private health information in any message you send us through this channel.

11/13/2025

At the Ivy Brain Tumor Center, we believe in the power of kindness. How are you showing yours today?

$Navigating a relapsed or refractory primary central nervous system lymphoma? At the Ivy Center, we are now enrolling a c...$

11/12/2025

Navigating a relapsed or refractory primary central nervous system lymphoma? At the Ivy Center, we are now enrolling a clinical trial studying anti-cancer activity of Emavusertib (CA-4948).
Determine your eligibility today: https://bar.rw/4pnvdwn
☎️: 602-406-8605

11/10/2025

Want the inside scoop on brain tumor research, inspiring patient journeys, and upcoming community events? Get it all delivered straight to your inbox! Sign up now: ➡️https://bar.rw/3JV2Juz

11/07/2025

We are excited to be exhibiting at SNO 2025! Be sure to visit our booth from November 19-22; we'd love to see you!

11/06/2025

The Ivy Center hosted a live brain surgery viewing event for Barrow Neurological Foundation donors, members of the Women’s Board, and the Board of Trustees. Guests received an introduction from Dr. Papadopoulos and observed a brain tumor removal surgery performed by Dr. Sanai. The event offered a unique opportunity for our supporters to see firsthand the dedication and innovation driving progress in brain tumor care.

11/05/2025

📣 A new clinical trial is now open for patients with recurrent . This study is testing BMS-986504 and includes a therapeutic expansion phase for patients who have positive results in the initial phase of the trial.

🌐: https://bar.rw/3LK3AyE
✉️: Research@IvyBrainTumorCenter.org

11/04/2025

Exciting news! Dr. Umemura has been invited to give a talk on Integrating IDH Inhibitor Therapy Into Glioma Care at SNO. Participants will gain increased knowledge regarding key clinical data evaluating novel and emerging therapies for IDH mutations in gliomas. Don't miss it!

11/03/2025

What an inspiring success! The 2025 Head For The Cure 5K in Phoenix brought our community together beautifully. We're so grateful to everyone who joined us to advance brain cancer awareness and research. Your passion is the heart of this cause! If you couldn't make it, you can still support our efforts by donating at the event website. With Head for the Cure's ongoing partnership, the Ivy Brain Tumor Center continues to advance its mission to improve patient outcomes. We can't wait for next year! Donate here: https://bar.rw/3X4abGD

10/31/2025

Understanding Meningiomas

Meningiomas are 'primary' brain tumors that derive from the meninges, the protective lining of the brain. While most patients with a meningioma will have a tumor at only one site, it is possible to have several tumors growing simultaneously in different parts of the brain. These tumors can directly infiltrate the brain tissue, but their symptoms are most often due to their mass effect on the brain.

Did you know? Grade I meningiomas are the most common type and is generally treated with surgery alone.

Learn more: https://bar.rw/436TT3v

10/30/2025

Metastatic Brain Tumors

Unlike primary brain tumors (which start in the brain), metastatic brain tumors, or 'secondary' brain tumors, originate from cancer in another part of the body and spread to the brain. The most common sources of brain metastases are cancers from the lung, breast, skin, kidney, and colon.

These tumors are usually treated with surgery that is sometimes followed by radiation or stereotactic radiosurgery.

Did you know? Metastatic tumors are the most common brain tumor. Up to 40 percent of systemic cancer patients develop brain metastases.

The Ivy Center remains dedicated to advancing brain tumor treatment. Learn more: https://bar.rw/47MBGL4

10/29/2025

Understanding Gliomas

Gliomas are primary brain tumors that originate from the brain tissue itself. This tissue is called "gila," and it helps to keep the neurons in place and functioning well. Common subtypes include astrocytoma, oligodendroglioma, glioblastoma, and gliosarcoma.

All gliomas are graded based on World Health Organization (WHO) criteria: Grade I to IV. Grades I, II, and III gliomas are less aggressive and often seen in younger populations, yet can still recur and defy conventional therapies. Grade IV gliomas (known as glioblastomas or gliosarcomas) are the most common primary brain cancer in adults.

Did you know? All Glioblastomas are Gliomas, but not all Gliomas are Glioblastomas.

The Ivy Center specializes in researching and treating these complex tumors. Learn more: https://bar.rw/4qv41x3

10/29/2025

Looking for different treatment options for your glioblastoma? Talk to an Ivy Navigator today about eligibility for a Phase 0 clinical trial evaluating a novel experimental targeted therapy.

☎️ 602-406-8605
✉️ Research@IvyBrainTumorCenter.org
🌐 https://bar.rw/4hvWBFu

Address

2910 North Third Avenue
Phoenix, AZ
85013

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+16024066489

Website

http://www.ivybraintumorcenter.org/

Alerts

Be the first to know and let us send you an email when Ivy Brain Tumor Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ivy Brain Tumor Center:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Featured

Ahwatukee Psychology
11011 S 48th Street, Ste 106

Want your practice to be the top-listed Clinic in Phoenix?